RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 m
Recalled September 23, 2020 · FDA recall D-1606-2020 · RLC Labs
Hazard
CGMP Deviations: manufactured under the same conditions as those found to be subpotent. · FDA Class II
Units
N/A
Sold at
Nationwide in the United States
Description
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Product
WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-5450-4; b) 60-count bottles, NDC 64727-5450-5; c) 90-count bottles, NDC 64727-5450-6; d) 100-count bottles, NDC 64727-5450-1; and e) 1,000-count bottles, NDC 64727-5450-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.
Manufacturer(s)
RLC Labs Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →